IQN Path Selects SeraCare Life Sciences for First-Ever Tumor Mutational Burden External Quality Assessment Program
International expert group focused on improving quality of clinical biomarker testing launching pilot TMB proficiency program in Spring 2019 MILFORD, Mass., WED. March 27, 2019 /PRNewswire/ — SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today their successful selection as a technology partner read more…
New article in the journal BMC Cancer
IQN Path has an article from the liquid biopsy working group published in the journal BMC Cancer entitled: “International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA” The full article can be found here at this link: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4694-x
Come and see IQN Path at the ECP 2018 Exhibition
IQN Path will again have a stand at the 30th European Congress of Pathology being held on 8th – 12th September 2018 in the Euskalduna Conference Centre in Bilbao, Spain. We will be using the stand to meet with both current IQN Path members and new potential members. We are Stand number 18 in Hall read more…
New IQN Path Board Announced
IQN Path Members Area
One of the benefits of being a member of IQN Path is that all member organisations have access to our secure member’s area on the IQN Path website. In this area we post all manner of papers including Governance documents and the Annual IQN Path report. Meeting summaries and agendas, both general meetings but also read more…
The IQN Path AGM is approaching on 11th May 2018
A reminder to all IQN Path members, please make a note in your agendas to register for the IQN Path Annual General Meeting being held on Friday 11th of May 2018. If you have key topics you would like to add to the business meeting regarding future directions and strategies or new project ideas, please read more…
Calling All EQA Members!
Elections for Two Seats on the IQN Path Board The Founding Board of IQN Path has now fulfilled its first term of office and we are now looking for expressions of interest from within the EQA scheme membership to become an IQN Path Executive Board Member for the available seats. In order to provide continuity read more…
Article published in The Pathologist
IQN Path, in collaboration with Ventana Medical Systems, have published an article in The Pathologist entitled ‘A Quality Undertaking – Connecting EQA and industry to ensure quality diagnostic testing’. This short article explores the difficulties in standardisation for accuracy and precision in the EQA process and ways that IQN Path is working in collaboration with read more…
IQN Path PD-L1 digital educational resource for EQA
IQN Path is working on setting up a new project to support quality of PDL1 testing. The goal of the project, is to establish a high quality education resource for self-assessment of pathologists on PD-L1 scoring. Digital slides stained with the four different FDA approved tests (from both Agilent and Roche) will be available to view. The digital platform read more…